InvestorsHub Logo
Followers 18
Posts 6668
Boards Moderated 0
Alias Born 03/06/2010

Re: The ELTP King post# 250211

Saturday, 04/08/2017 9:14:06 PM

Saturday, April 08, 2017 9:14:06 PM

Post# of 402086
Stock decrease has coincided with equity offerings. Half of company's 300M valuation is from 150M in the bank.

Here is info about Collegium's Xtampza: UnitedHealth will make Xtampza exclusive from Q1 onwards, at the expense of OxyContin.

Xtampza is expected to bring in 50M or 1% of potential market by end of 2017. Company burns 100M cash per year so plenty of expense to cut if sales don't materialize.

Xtampza ramp rate of scrips is eye opener for those that think SequestOx will "own" markets overnight. Not a chance.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News